Diverticular Disease is a digestive disorder that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular Disease can be caused by many factors such as low fiber diet, lack of physical exercise, and certain medications like anti-inflammatory drugs, lack of vitamin D, obesity, and smoking.
The global Diverticular disease market is expected to grow a healthy growth at a CAGR of 7.5% during the forecast period.
Segmentation
The global Diverticular disease market is segmented on the basis of type, treatment, diagnosis and end-users.
On the basis of the type, the market is segmented into diverticulosis, diverticulitis, and diverticular bleeding.
On the basis of treatment, the market is segmented into medications, supportive care, and surgery. The medication segment is further sub-segmented into antibiotics, penicillin antibiotics, and dietary supplements. The supportive Care segment is further sub-segmented into IV fluids.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/5694
Regional Analysis:
The Americas dominate the global Diverticular disease market owing to the rising aging population and increasing rate in cigarette smokers. Additionally, rising obesity rates along with increasing healthcare expenditure are likely to enhance the growth of Diverticular disease in the North American region.
According to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the U.S. as of 2016. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion was spent on healthcare expenditure in the U.S.
Europe accounts for the second-largest market due to increasing aging mass and increasing obesity rates. Additionally, improving government support and increasing healthcare infrastructure along with rising demand for technologically advanced treatment is driving the growth of Diverticular disease market in Europe.
Have Any Query? Connect with Our Research Expert 24*7:https://www.marketresearchfuture.com/enquiry/5694
Key Players
Some of the key players in the Diverticular disease market are Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Abbott Laboratories, Synergy Pharmaceuticals, Inc.Ardelyx, Inc., Astellas Pharma Inc., and Novartis AG.
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.